Effect of evacetrapib on cardiovascular outcomes in patients with high-risk cardiovascular disease

被引：0
|
作者：
Aronow, Wilbert S. [1 ,2 ]
机构：
[1] Westchester Med Ctr, Div Cardiol, Dept Med, Valhalla, NY USA
[2] New York Med Coll, Macy Pavilion,Room 141, Valhalla, NY 10595 USA
来源：
JOURNAL OF THORACIC DISEASE | 2017年 / 9卷 / 07期
关键词：
TRANSFER PROTEIN-INHIBITION; HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; EFFECTIVE STRATEGY; TORCETRAPIB; CHOLESTEROL; THERAPY; EVENTS; TARGET; MEN;
D O I：
10.21037/jtd.2017.06.106
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：1822 / 1825
页数：4
相关论文
共 50 条
  • [1] Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
    Lincoff, A. M.
    Nicholls, S. J.
    Riesmeyer, J. S.
    Barter, P. J.
    Brewer, H. B.
    Fox, K. A. A.
    JOURNAL OF VASCULAR SURGERY, 2017, 66 (04) : 1302 - 1302
  • [2] Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
    Lincoff, A. Michael
    Nicholls, Stephen J.
    Riesmeyer, Jeffrey S.
    Barter, Philip J.
    Brewer, H. Bryan
    Fox, Keith A. A.
    Gibson, C. Michael
    Granger, Christopher
    Menon, Venu
    Montalescot, Gilles
    Rader, Daniel
    Tall, Alan R.
    McErlean, Ellen
    Wolski, Kathy
    Ruotolo, Giacomo
    Vangerow, Burkhard
    Weerakkody, Govinda
    Goodman, Shaun G.
    Conde, Diego
    McGuire, Darren K.
    Nicolau, Jose C.
    Leiva-Pons, Jose L.
    Pesant, Yves
    Li, Weimin
    Kandath, David
    Kouz, Simon
    Tahirkheli, Naeem
    Mason, Denise
    Nissen, Steven E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (20): : 1933 - 1942
  • [3] Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease
    Boehm, Michael
    Schumacher, Helmut
    Laufs, Ulrich
    Sleight, Peter
    Schmieder, Roland
    Unger, Thomas
    Teo, Koon
    Yusuf, Salim
    AMERICAN HEART JOURNAL, 2013, 166 (02) : 306 - +
  • [4] ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease A Nested Case-Control Study
    Nissen, Steven E.
    Pillai, Sreekumar G.
    Nicholls, Stephen J.
    Wolski, Kathy
    Riesmeyer, Jeffrey S.
    Weerakkody, Govinda J.
    Foster, Wendra M.
    McErlean, Ellen
    Li, Lin
    Bhatnagar, Pallav
    Ruotolo, Giacomo
    Lincoff, A. Michael
    JAMA CARDIOLOGY, 2018, 3 (05) : 401 - 408
  • [5] Genome-Wide Polygenic Score and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease A Nested Case-Control Study
    Emdin, Connor A.
    Bhatnagar, Pallav
    Wang, Minxian
    Pillai, Sreekumar G.
    Li, Lin
    Qian, Hui-Rong
    Riesmeyer, Jeffrey S.
    Lincoff, A. Michael
    Nicholls, Stephen J.
    Nissen, Steven E.
    Ruotolo, Giacomo
    Kathiresan, Sekar
    Khera, Amit V.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (01): : E002767
  • [6] Appropriate strategies for the cardiovascular "disease". High-risk patients
    Caballero Gueeto, Juliana
    Ulecia Martinez, Miguel Angel
    Gonzalez Cocina, Emilio
    Lagares Carballo, Manuel
    MEDICINA CLINICA, 2009, 133 (07): : 261 - 271
  • [7] Influenza Vaccine for Patients With High-risk Cardiovascular Disease
    Patel, Manish M.
    Uyeki, Timothy M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (01): : 33 - 35
  • [8] The cardiovascular polypill in high-risk patients
    Lafeber, Melvin
    Spiering, Wilko
    Singh, Kavita
    Guggilla, Rama K.
    Patil, Vinodvenkatesh
    Webster, Ruth
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (06) : 1234 - 1242
  • [9] ASSOCIATION OF HSCRP WITH HIGH-RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH SCHIZOPHRENIA
    Yao, Jeffrey K.
    Reddy, R.
    Dougherty, G.
    Magan, S.
    Gurklis, J.
    Sonel, A.
    Sonel, E.
    Kisslinger, B.
    Keshavan, Matcheri
    Chengappa, K.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 120 - 120
  • [10] Effect of ramipril on cardiovascular events in high-risk patients.
    O'Rourke, MF
    Nichols, WW
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (01): : 64 - 65
12345